Latest Financials News

Decidr AI Industries reported an 82% revenue jump in its AI platform during Q4 FY25, launched AI Mentors with The Growth Faculty, and divested its 13Seeds business to sharpen focus on AI innovation.

Core Energy Minerals has initiated its first aircore drilling program at the Cummins Uranium Project in South Australia, while confirming uranium mineralisation in Brazil and refinancing its convertible notes to support ongoing exploration.

Ionic Rare Earths advances its rare earths strategy with major UK government funding, Brazilian JV progress, and US expansion talks amid China export controls.

xReality Group delivered a strong Q4 FY25 with $4.7 million in cash receipts, driven by growth in its Operator XR enterprise software and entertainment divisions, alongside a $2 million placement to institutional investors supporting international expansion.

Micro-X has landed a significant supply agreement with a top US healthcare provider for its Rover Plus mobile X-ray units, while progressing clinical trials and development milestones for its innovative CT imaging products.

iTech Minerals has significantly extended the strike length of gold-antimony mineralisation at its Reynolds Range Project, revealing new high-priority drill targets and advancing its lithium deal with SQM.

Electro Optic Systems (EOS) has secured its largest-ever order for the Slinger Counter-Drone system, boosting its contract backlog by 25% to $170 million and reporting strong cash flow and a debt-free balance sheet.

Great Divide Mining has taken a decisive step towards becoming a near-term gold producer through a new joint venture with Dart Mining and securing a Queensland government grant for exploration.

Doctor Care Anywhere has reported a landmark positive operating and investing cash inflow in Q2 2025, alongside modest consultation growth and strategic service expansion. The company reiterates its ambitious revenue and profitability targets amid ongoing cost transformation.

Odessa Minerals reports encouraging base metal anomalies and uranium exploration progress at its Lyndon Project, alongside strategic board changes and ongoing acquisition reviews.

Cluey Ltd has achieved its first-ever positive operating cash flow in Q4 FY25, marking a pivotal shift towards sustainable growth powered by AI innovation and expanded market reach.

Control Bionics capped a record FY25 with 15% revenue growth, driven by US market gains and expanding NeuroNode and NeuroStrip technologies. The company also achieved a US profitability milestone and is close to finalizing key distribution partnerships.